Compounds are described that are useful for treating an apoptosis-associated disease, which are specifically cytotoxic to tumor cells that are overexpressing Bcl-x
L
, and are much less cytotoxic in isogenic cells that are not overexpressing Bcl-x
L
. Also described is a method for treating an apoptosis-associated disease in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of an active compound that is specifically cytotoxic to tumor cells that are overexpressing Bcl-x
L
, and are much less cytotoxic in isogenic cells that are not overexpressing Bcl-x
L
. Several scaffolds of active compounds are described.
COMPOUNDS AND THERAPEUTIC USES
申请人:Unity Biotechnology, Inc.
公开号:US20170281649A1
公开(公告)日:2017-10-05
Disclosed herein are compounds that are effective for treatment of various disease states associated with senescence. The disclosed compounds can be used to eliminate senescent cells for disease treatment. The dosing of the compounds includes both single administration and regimens of cycling dosages.
US8865901B2
申请人:——
公开号:US8865901B2
公开(公告)日:2014-10-21
[EN] METHOD OF INHIBITING BCL-2-RELATED SURVIVAL PROTEINS<br/>[FR] PROCÉDÉ DESTINÉ À INHIBER DES PROTÉINES DE SURVIE APPARENTÉES AUX BCL-2
申请人:HUTCHINSON FRED CANCER RES
公开号:WO2011041731A2
公开(公告)日:2011-04-07
A method for treating an apoptosis-associated disease in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of an active compound that is specifically cytotoxic to tumor cells that are overexpressing Bcl-xL, and are much less cytotoxic in isogenic cells that are not overexpressing Bcl-xL. Several scaffolds of active compounds are described.
2-Hydroxyphenyl Sulfoxides and 2-Hydroxyphenyl Sulfones